|

Empagliflozin (SGLT2i) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • Hotel Dieu de France Hospital1

Indications

  • SGLT 2 Inhibitors1
  • PCI1
  • CAD - Coronary Artery Disease1
  • Inflamation1
  • Heart Disease1

Other1 trial

Effect of Empagliflozin on Inflammation
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.